Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 9:42 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2425–2448 of 3,983 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Voiding Disorders
Interventions: Simultaneous functional MRI and urodynamic studies, Questionnaires, Post Void Residual (PVR), Uroflow and Bladder Diary, Urinalysis; Diagnostic Test · Behavioral · Other
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 45 Years to 90 Years · Male only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Parkinson Disease
Interventions: Augmented Reality Multi-Modal Training, Traditional Multi-Modal Training; Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hearing Loss, Dementia, Cognitive Impairment
Interventions: HEARS-SLP device, HEARS-SLP program; Device · Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 60 Years to 100 Years
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Platelet Dysfunction, Traumatic Brain Injury
Interventions: Platelet mapping Thromboelastography; Diagnostic Test
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 55 Years and older
Enrollment: 147 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Breast Cancer, Non-Hodgkin's Lymphoma
Interventions: Mesna, Saline, Doxorubicin, Cyclophosphamide; Drug
Lead sponsor: Mara Chambers; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Mild Cognitive Impairment, Dementia, Mild
Interventions: Precision Medicine Approach, Hormones and Medications tailored to lab tests, combined with devices that support stress management and brain exercises, Standard-of-Care, Lifestyle including diet, exercise, stress management; Dietary Supplement · Combination Product · Behavioral
Lead sponsor: Alzheimer's Prevention and Reversal Project, Inc.; Other
Eligibility: 45 Years to 76 Years
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 6
States / cities: Folsom, California • San Rafael, California • Walnut Creek, California + 3 more

Conditions: Postoperative Delirium, Sleep, Anesthesia
Interventions: Dexmedetomidine, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 60 Years and older
Enrollment: 469 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Quality of Life, Cognitive Decline, Fatigue, Sleep, Anxiety, Depression
Interventions: Physical activity experiment, Balance and flexibility control; Behavioral
Lead sponsor: American Cancer Society, Inc.; Other
Eligibility: 55 Years to 77 Years
Enrollment: 415 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Kennesaw, Georgia

Conditions: Mild Cognitive Impairment, Alzheimer Disease
Interventions: Allopregnanolone injection (intravenous solution), Placebo injection (intravenous solution); Drug
Lead sponsor: University of Southern California; Other
Eligibility: 55 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Premature Infant
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Up to 3 Years
Enrollment: 393 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Erectile Dysfunction
Interventions: Erchonia HLS; Device
Lead sponsor: Erchonia Corporation; Industry
Eligibility: 40 Years to 80 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Heart Failure, Coronary Artery Disease, Peripheral Artery Disease, Ischemia, Hypertension, Diabetes Mellitus, Cardiomyopathies, Cardiotoxicity
Interventions: Clinical Decision Aid, Standard Care; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Interstitial Cystitis, Sacroiliac Joint Somatic Dysfunction
Interventions: Osteopathic Manipulation Therapy; Procedure
Lead sponsor: Pelvic and Sexual Health Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Temporomandibular Joint Dysfunction
Interventions: arthrocentesis, arthroscopy, arthroplasty; Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Neurological Manifestations
Interventions: Optimizing hemodynamic and anesthetic parameters to improve cerebral perfusion; Device
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years to 90 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Cannabinoid Hyperemesis Syndrome
Interventions: Haloperidol; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Mild Cognitive Impairment (MCI), Memory Disorders, Age Related, Memory Decline
Interventions: Piano lessons, Music Lessons; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 60 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Coronary Artery Disease, Heart Failure Systolic
Interventions: Revascularization by PCI, Revascularization by CABG; Procedure
Lead sponsor: Sunnybrook Health Sciences Centre; Other
Eligibility: 18 Years and older
Enrollment: 754 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 6
States / cities: Los Angeles, California • New Haven, Connecticut • Louisville, Kentucky + 3 more

Conditions: Vulvovaginal Atrophy
Interventions: no intervention; Other
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 90 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Erectile Dysfunction
Interventions: Nebivolol, Sugar Pill; Drug
Lead sponsor: Martin M. Miner, MD; Other
Eligibility: 25 Years to 65 Years · Male only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 3
States / cities: Providence, Rhode Island

Conditions: Osteoarthritis, Knee, Dementia
Interventions: Tai Chi, Attention control; Behavioral
Lead sponsor: University of Arkansas; Other
Eligibility: 60 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Depression, Side Effects, Sexual Dysfunction, Apathy
Interventions: Wellbutrin XL; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Alzheimer Disease, Mild Cognitive Impairment
Interventions: Placebo, Eligard 22.5Mg Suspension for Injection; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 60 Years to 120 Years · Female only
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 3
States / cities: Boca Raton, Florida • New York, New York • Madison, Wisconsin

Conditions: Cognitive Impairment, Creativity
Interventions: Musical arts intervention; Behavioral
Lead sponsor: William Marsh Rice University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Brain Imaging in Men With Lower Urinary Tract Symptoms

Dual-task Augmented Reality Treatment for Parkinson's Disease

HEARS-SLP: Providing SLP-Delivered Hearing Health Care to Individuals With Cognitive Impairment

Correcting Platelet Dysfunction After Traumatic Brain Injury

Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release

Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep

Health and Energy Through Active Living Every Day After Cancer Intervention for Cancer Survivors

Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD

Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)

Effect of Erchonia Laser on Erectile Dysfunction

PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study

Osteopathic Manipulation for Female Interstitial Cystitis Patients With Sacroiliac Joint Dysfunction

A Comparison of Arthrocentesis, Arthroscopy and Arthroplasty in the Treatment of Temporomandibular Joint Dysfunction

Brain Oxygenation Monitoring in Patients Undergoing Coronary Artery Bypass Surgery

Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department

Music for the Mind Study

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

High Tone Pelvic Floor Dysfunction

Nebivolol Effects on Endothelial Function and Erectile Function

Effect of Tai Chi on Osteoarthritic Knee Pain in Elders With Mild Dementia

Wellbutrin XL Effects on SSRIs Induced Changes

The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's

Cognitive Health Research on Musical Arts